Navigation Links
Hospira Receives TGA Approval for Nivestim™, Australia's First Biosimilar Filgrastim
Date:9/26/2010

MELBOURNE, Australia, Sept. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration (TGA) approval for its biosimilar filgrastim product, Nivestim™.

Nivestim has been approved for a range of indications, including the prevention of febrile neutropenia (FN) and reduction in duration of chemotherapy-induced neutropenia (CIN). Neutropenia is the most serious hematological toxicity that occurs as a result of cancer chemotherapy and can lead to chemotherapy dose reductions and/or dose delays compared with the prescribed schedule.(1)

Nivestim is the first biosimilar version of Neupogen® approved in Australia. Neupogen has current sales within Australia of approximately AUD25 million (U.S. $24 million). Hospira is working closely with Australian government agencies to ensure efficient market access for biosimilars, and has submitted an application to have Nivestim listed on the Australian Pharmaceutical Benefits Scheme. Listing and product launch are expected during the first half of 2011.

"Approval of Nivestim, the first biosimilar filgrastim in Australia, is another important milestone for Hospira as we build our global biosimilars portfolio," said Tim Oldham, president, Asia Pacific, Hospira. "Nivestim will help reduce the cost of providing this lifesaving therapy across Australia, and includes a unique combination of administration, storage and safety features that will enhance safety for healthcare professionals and patients."

Three pre-filled syringe presentations of Nivestim were approved in Australia: 300 mcg/0.5 mL, 480 mcg/0.5 mL and a unique 120 mcg/0.2 mL low body weight presentation.

In a large, randomized Phase lll study, Nivestim demonstrated comparable efficacy to Neupogen in the prevention o
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
2. Hospira Announces CEO Succession Plan
3. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
4. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
5. Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections
6. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
7. Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
8. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
9. Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP
10. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
11. Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015   Cochlear Limited (ASX: ... announced today the US Food and Drug Administration ... with Slim Straight Electrode (CI522). Built on over ... collaboration with the world,s leading surgeons, the Profile ... to provide the most discreet appearance for both ...
(Date:7/1/2015)... 2015  goBalto, Inc., the leading provider of ... growth in serving pharmaceutical, biotech and CRO companies. ... clinical trials and restrain costs, but inefficiencies tied ... stalled these efforts," said Sujay Jadhav , ... has encouraged Industry leaders, to embrace cloud-based solutions. ...
(Date:7/1/2015)... Ariz. , July 1, 2015 Prismic ... drugs and FDA-regulated medical foods, today announced the election ... A. Simonetti to its Board of Directors. ... Board members, Peter Moriarty , Chairman and CEO ... Krivulka and Martin Simonetti have accepted ...
Breaking Medicine Technology:Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2
... announces that a new market research report is ... A Preventive Vaccines - Pipeline Assessment and Market ... Hepatitis A Preventive Vaccines - ... SummaryGlobalData, the industry analysis specialist, has ...
... March 14, 2011 Reportlinker.com announces that a ... catalogue: Insulin Lispro - Comprehensive ... Eliminate unnecessary risk with the industry ... Developer is a regularly updated, professional patent search ...
Cached Medicine Technology:Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Insulin Lispro - Comprehensive Patent Search 2Reportlinker Adds Insulin Lispro - Comprehensive Patent Search 3Reportlinker Adds Insulin Lispro - Comprehensive Patent Search 4
(Date:7/2/2015)... Somerset, N.J. (PRWEB) , ... July 02, 2015 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Eberbach, Germany, facilities. , Dr. Irmgard Neuper is the new General Manager at ...
(Date:7/2/2015)... ... ... can have an effect on the body. And during the hot summer season, fitness guru ... eating enough of the right foods, as well as drinking plenty of water. , But ... the food front as well, with sweet treats like ice cream and snow cones more popular ...
(Date:7/2/2015)... ... July 02, 2015 , ... Denver-based SlimGenics Weight Control ... was named No. 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz ... been recognized. The award identifies outstanding woman-owned businesses that demonstrate excellence and success ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. Jian-Dong Li, a ... and a Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received ... infections. , The grant from the National Institute on Deafness and Other Communication ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... that they will welcome four new members to their industry leading Scientific Advisory ...
Breaking Medicine News(10 mins):Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5
... Chairman, Tony Strange Appointed to CEO position and Will Join ... , MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ -- ... a leading provider of comprehensive home health services, announced today ... plan. Effective January 1, 2009, Tony Strange will become ...
... by contact with blood, respiratory secretion , , TUESDAY, Nov. ... of a tick-borne disease called granulocytic anaplasmosis (HGA), which ... described in a study by researchers at China,s National ... the first known report of human-to-human transmission of HGA. ...
... of Michigan is,asking Attorney General Mike Cox to stand ... that are,included in a compromise on health insurance reform ... conference committee of the Michigan House and,Senate. , ... has a vested interest in ensuring that all,Michigan consumers ...
... allergic reactions, other problems have surfaced with these products, ... American women who turn to cosmetic treatments called dermal ... to the health risks these products pose, an advisory ... Tuesday. , The panel of independent experts urged the ...
... SEATTLE, Nov. 18 Just in time ... new Web site http://www.ShopForCancerCures.org to,benefit ... Center,( http://www.fhcrc.org ) and 10 other world-class ... ( http://www.cancerresearchalliance.org ). A portion of,each purchase ...
... ability to live and function when enrolled in tailored interventions ... get elderly cancer survivors to eat better and exercise more ... a new study says. , The Texas study found ... ability, lost weight and body mass when enrolled in a ...
Cached Medicine News:Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4Health News:China Documents First Case of Tick-Borne Disease Spread 2Health News:Blue Cross Blue Shield of Michigan Calls for Attorney General to Support Stronger Regulation of Commercial Insurers; Protections for Consumers; and Financially Stable Insurance Market 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 3Health News:Fred Hutchinson Cancer Research Center Benefits From Shopping Site 2Health News:Fred Hutchinson Cancer Research Center Benefits From Shopping Site 3Health News:Home-Based Programs Benefit Older Cancer Survivors 2
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (P3797) ... assistance. Color: colour-coded ...
... PYREX serological pipets are calibrated "to deliver" ... use in confined areas such as hoods. ... and feature negative and reverse graduations to ... measuring procedures. Packaged in plastic bags so ...
Corning 7078A multi-pack plugged capacity 5 mL...
Corning 7077B L 215 mm volume 5.0 0.1 mL...
Medicine Products: